Advances in the methods for discovering novel painful bladder syndrome therapies

Bibliography

• Christmas TJ. Historical aspects of interstitial cystitis. In: Sant GR, editor, Interstitial cystitis. Lippincott-Raven, Philadelphia; 1997. p. 108; chapter 1
   Google Scholar
• Teichman JM, Thompson IM, Taichman NS. Joseph Parrish, tic doloureux of the bladder and interstitialcystitis. J Urol 2000;164:1473-5
   PubMed Web of Science ®Google Scholar
• Hunner GL. A rare type of bladder ulcer in women; report of cases. Boston Med Surg J 1915;172:660-4
   Google Scholar
• Hand JR. Interstitial cystitis: report of 223 cases (204 women and 19 men). J Urol 1949;61:291-310
   PubMed Web of Science ®Google Scholar
• Messing EM, Stamey TA. Interstitial cystitis: early diagnosis, pathology, and treatment. Urology 1978;12:381-92
   PubMedGoogle Scholar
• Hanno P, Lin A, Nordling J, et al. Bladder pain syndrome committee of the international consultation on incontinence. Neurourol Urodyn 2010;29:191-8
   PubMed Web of Science ®Google Scholar
• Gillenwater JY, Wein AJ. Summary of the national institute of arthritis, diabetes, digestive and kidney diseases workshop on interstitial cystitis, national institutes of health, bethesda, maryland. J Urol 1998;140:203-6
   Google Scholar
• Van de Merwe JP, Nordling J, Bouchelouche P, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol 2008;53:60-7
   PubMed Web of Science ®Google Scholar
• Vij M, Srikrishna S, Cardozo L. Interstitial cystitis: diagnosis and management. Eur J Obstet Gynecol Reprod Biol 2012;161:1-7
   PubMed Web of Science ®Google Scholar
• Persu C, Cauni V, Gutue S, et al. From interstitial cystitis to chronic pelvic pain. J Med Life 2010;3:167-74
   PubMedGoogle Scholar
• Butrick CW. Patients with chronic pelvic pain: endometriosis or interstitial cystitis/painful bladder syndrome? JSLS 2007;11:182-9
   PubMedGoogle Scholar
• Moutzouris DA, Falagas ME. Interstitial cystitis:an unsolved enigma. Clin J Am Soc Nephrol 2009;4:1844-57
   PubMed Web of Science ®Google Scholar
• National Institute of Diabetes and Digestive and Kidney Diseases. Multi-disciplinary approach to the study of chronic pelvic pain (MAPP) research network [grant announcement]. 2007. Available from: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-07-003.html
   Google Scholar
• International Painful Bladder Foundation. IPBF E-newsletter. 2007. Available from: http://www.painful-bladder.org/pdf/2007_12_Newsletter.pdf
   Google Scholar
• Erickson DR, Tomaszewski JE, Kunselman AR, et al. Do the national institute of diabetes and digestive and kidney diseases cystoscopic criteria associate with other clinical and objective features of interstitial cystitis? J Urol 2005;173:93-7
   PubMed Web of Science ®Google Scholar
• Slobodov G, Feloney M, Gran C, et al. Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis. J Urol 2004;171:1554-8
   PubMed Web of Science ®Google Scholar
• Hurst RE, Roy JB, Min KW, et al. A deficit of chondroitin sulfate proteoglycans on the bladder uroepithelium in interstitial cystitis. Urology 1996;48:817-21
   PubMed Web of Science ®Google Scholar
• Graham E, Chai TC. Dysfunction of bladder urothelium and bladder urothelial cells in interstitial cystitis. Curr Urol Rep 2006;7:440-6
   PubMedGoogle Scholar
• Hurst RE, Moldwin RM, Mulholland SG. Bladder defense molecules, urothelial differentiation, urinary biomarkers, and interstitial cystitis. Urology 2007;69:17-23
   PubMed Web of Science ®Google Scholar
• Parsons CL, Stein P, Zupkas P, et al. Defective tamm-horsfall protein in patients with interstitial cystitis. J Urol 2007;178:2665-70
   PubMed Web of Science ®Google Scholar
• Parsons CL. The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis. Urology 2007;69:9-16
   PubMed Web of Science ®Google Scholar
• Theoharides TC, Kempuraj D, Sant GR. Mast cell involvement in interstitial cystitis: a review of human and experimental evidence. Urology 2001;57:47-55
   PubMed Web of Science ®Google Scholar
• Sant GR, Kempuraj D, Marchand JE, Theoharides TC. The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology 2007;69:34-40
   PubMed Web of Science ®Google Scholar
• Bouchelouche K, Kristensen B, Nordling J, et al. Increased urinary leukotriene E4 and eosinophil protein X excretion in patients with interstitial cystitis. J Urol 2001;166:2121-5
   PubMed Web of Science ®Google Scholar
• Keay S, Seillier-Moiseiwtsch F, Zhang CO, et al. Changes in human bladder epithelial cell gene expression associated with interstitial cystitis or antiproliferative factor treatment. Physiol Genomics 2003;14:107-15
   PubMed Web of Science ®Google Scholar
• Keay S, Zhang CO, Shoenfelt JL, Chai TC. Decreased in vitro proliferation of bladder epithelial cells from patients with interstitial cystitis. Urology 2003;61:1278-84
   PubMed Web of Science ®Google Scholar
• Wesselmann U. Interstitial cystitis: a chronic visceral pain syndrome. Urology 2001;57:32-9
   PubMed Web of Science ®Google Scholar
• Nazif O, Teichman JM, Gebhart GF. Neural upregulation in interstitial cystitis. Urology 2007;69:24-33
   PubMed Web of Science ®Google Scholar
• Ustinova EE, Fraser MO, Pezzone MA. Colonic irritation in the rat sensitizes urinary bladder afferents to mechanical and chemical stimuli: an afferent origin of pelvic organ cross-sensitization. Am J Physiol Renal Physiol 2006;290:F1478
   Google Scholar
• Elbadawi AE, Light JK. Distinctive ultrastructural pathology of nonulcerative interstitial cystitis; new observations and their pathological significance in pathogenesis. Urol Int 1996;56:137-62
   PubMed Web of Science ®Google Scholar
• Schwalenberg T, Stolzenburg JU, Ho TP, et al. Enhanced urothelial expression of human chorionic gonadotropin beta (hCGβ) in bladder pain syndrome/interstitial cystitis (BPS/IC). World J Urol 2012;30:411-17
   PubMed Web of Science ®Google Scholar
• Peeker R, Aldenborg F, Dahistorm A, et al. Increased tyrosine hydroxylase immunoreactivity in bladder tissue from patients with classic and non-ulcer interstitial cystitis. J Urol 2000;163:1112-15
   PubMed Web of Science ®Google Scholar
• Keay S, Kleinberg M, Zhang CO, et al. Bladder epithelial cells from patients with interstitial cystitis produce an inhibitor of heparin-binding epidermal growth factor-like growth factor production. J Urol 2000;164:2112-18
   PubMed Web of Science ®Google Scholar
• Dimitrakov J, Guthrie D. Genetics and phenotyping of urological chronic pelvic pain syndrome. J Urol 2009;181:1550-7
   PubMed Web of Science ®Google Scholar
• Hsieh CH, Chang WC, Huang MC, et al. Treatment of interstitial cystitis in women. Taiwan J Obstet Gynecol 2012;51:526-32
   PubMed Web of Science ®Google Scholar
• Sasaki K, Smith CO, Chuang YC, et al. Oral gabapentin treatment of refractory genitourinary tract pain. Tech Urol 2001;7:47-9
   PubMedGoogle Scholar
• Tura B, Tura SM. The analgesic effect of tricyclic antidepressants. Brain Res 1992;518:19-22
   Web of Science ®Google Scholar
• Van Ophoven A, Hertle L. Long term results of amitriptyline treatment of interstitial cystitis. Urology 2005;174:1837-40
   Web of Science ®Google Scholar
• Hanno PM, Burks DA, Clemens Q, et al. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome. American Urological Association Guidelines Department, Linthicum, MD, USA: 2011
   Google Scholar
• Foster HE, Hanno PM, Nickel JC, et al. Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome. J Urol 2010;183:1853-8
   PubMed Web of Science ®Google Scholar
• Lewi HJ. Medical therapy in interstitial cystitis: the essex experience. Urology 2001;57:120
   PubMedGoogle Scholar
• Thilagarajah R, Witherow RO, Walker MM. Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double-blind placebo-controlled trial. BJU Int 2001;87:207-12
   PubMed Web of Science ®Google Scholar
• Dimitrakov J, Kroenke K, Steers WD, et al. Pharmacologic management of painful bladder syndrome/interstitial cystitis: a systematic review. Arch Intern Med 2007;167(18):1922-9
   PubMed Web of Science ®Google Scholar
• Seth A, Teichman JM. What's new in the diagnosis and management of painful bladder syndrome/interstitial cystitis? Curr Urol Rep 2008;9(5):349-57
   PubMedGoogle Scholar
• Colaco MA, Evans RJ. Current recommendations for bladder instillation therapy in the treatment of interstitial cystitis/bladder pain syndrome. Curr Urol Rep 2013;14:442-7
   PubMedGoogle Scholar
• Neuhaus J, Schwalenberg T. Intravesical treatments of bladder pain syndrome/interstitial cystitis. Nat Rev Urol 2012;9:707-20
   PubMed Web of Science ®Google Scholar
• Fowler JE Jr. Prospective study of intravesical dimethyl sulfoxide in treatment of suspected early interstitial cystitis. Urology 1981;18:21-6
   PubMed Web of Science ®Google Scholar
• Ghoniem GM, McBride D, Sood OP, Lewis V. Clinical experience with multiagent intravesical therapy in interstitial cystitis patients unresponsive to single agent therapy. World J Urol 1993;11:178-82
   PubMed Web of Science ®Google Scholar
• Generali JA, Cada DJ. Intravesical heparin: interstitial cystitis (painful bladder syndrome). Hosp Pharm 2013;48:822-4
   PubMedGoogle Scholar
• Engelhardt PF, Morakis N, Daha LK, et al. Long-term results of intravesical hyaluronan therapy in bladder pain syndrome/interstitial cystitis. Int Urogynecol J 2011;22:401-5
   PubMed Web of Science ®Google Scholar
• Van Agt S, Gobet F, Sibert L, et al. Treatment of interstitial cystitis by intravesical instillation of hyaluronic acid: a prospective study on 31 patients. Prog Urol 2011;21:218-25
   PubMed Web of Science ®Google Scholar
• Nickel JC, Hanno P, Kumar K, Thomas H. Second multicenter, randomized, double-blind, parallel-group evaluation of effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis/bladder pain syndrome. Urology 2012;79:1220-4
   PubMed Web of Science ®Google Scholar
• Nickel JC, Moldwin R, Lee S, et al. Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome. BJU Int 2009;103:910-18
   PubMed Web of Science ®Google Scholar
• Taneja R. Intravesical lignocaine in the diagnosis of bladder pain syndrome. Int Urogynecol J 2010;21:321-4
   Web of Science ®Google Scholar
• Nickel JC, Jain P, Shore N, et al. Continuous intravesical lidocaine treatment for interstitial cystitis/bladder pain syndrome: safety and efficacy of a new drug delivery device. Sci Transl Med 2012;4:143
   Google Scholar
• GuhaSarkar S, Banerjee R. Intravesical drug delivery: challenges, current status, opportunities and novel strategies. J Control Release 2010;148:147-59
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005;4:145-60
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Multifunctional nanocarriers. Adv Drug Deliv Rev 2006;58:1532-55
   PubMed Web of Science ®Google Scholar
• Fraser MO, Chuang YC, Tyagi P, et al. Intravesical liposome administration – a novel treatment for hyperactive bladder in the rat. Urology 2003;61:656-63
   PubMed Web of Science ®Google Scholar
• Chuang YC, Lee WC, Chiang PH. Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome. J Urol 2009;182:1393-400
   PubMed Web of Science ®Google Scholar
• Lee WC, Chuang YC, Lee WC, Chiang WC. Safety and dose flexibility clinical evaluation of intravesical liposome in patients with interstitial cystitis/painful bladder syndrome. Kaohsiung J Med Sci 2011;27:437-40
   PubMed Web of Science ®Google Scholar
• Chuang YC, Tyagi P, Huang CC, et al. Urodynamic and immunohistochemical evaluation of intravesical botulinum toxin a delivery using liposomes. J Urol 2009;182:786-92
   PubMed Web of Science ®Google Scholar
• Harrington DA, Sharma AK, Erickson BA, Cheng EY. Bladder tissue engineering through nanotechnology. World J Urol 2008;26:315-22
   PubMed Web of Science ®Google Scholar
• Pham QP, Sharma U, Mikos AG. Electrospinning of polymeric nanofibers for tissue engineering applications. Tissue Eng 2006;12:1197-211
   PubMedGoogle Scholar
• Han D, Gouma PI. Electrospun bioscaffolds that mimic the topology of extracellular matrix. Nanomedicine 2006;2:37-41
   PubMed Web of Science ®Google Scholar
• Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces 2010;75:1-18
   PubMed Web of Science ®Google Scholar
• Chang LC, Wu SC, Tsai JW, et al. Optimization of epirubicin nanoparticles using experimental design for enhanced intravesical drug delivery. Int J Pharm 2009;376:195-203
   PubMed Web of Science ®Google Scholar
• Gommersall L, Shergill IS, Ahmed HU, et al. Nanotechnology and its relevance to the urologist. Eur Urol 2007;52:368-75
   PubMed Web of Science ®Google Scholar
• Chertok B, Moffat BA, David AE, et al. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials 2008;29:487-96
   PubMed Web of Science ®Google Scholar
• Leakakos T, Ji C, Lawson G, et al. Intravesical administration of doxorubicin to swine bladder using magnetically targeted carriers. Cancer Chemother Pharmacol 2003;51:445-50
   PubMed Web of Science ®Google Scholar
• Astruc D, Boisselier E, Ornelas C. Dendrimers designed for functions: from physical, photophysical, and supramolecular properties to applications in sensing, catalysis, molecular electronics, and nanomedicine. Chem Rev 2010;110:1857-959
   PubMed Web of Science ®Google Scholar
• Tekade RK, Tathagata D, Virendra G, Narendra KJ. Exploring dendrimer towards dual drug delivery. J Microencapsul 2009;26:287-96
   PubMed Web of Science ®Google Scholar
• Andersen AV, Granlund P, Schultz A, et al. Long-term experience with surgical treatment of selected patients with bladder pain syndrome/interstitial cystitis. Scand J Urol Nephrol 2012;46:284-9
   PubMed Web of Science ®Google Scholar
• Fall M, Baranowski AP, Elneil S, et al. EAU guidelines on chronic pelvic pain. Eur Urol 2010;57:35-48
   PubMed Web of Science ®Google Scholar
• Gurocak S, Nuininga J, Ure I, et al. Bladder augmentation: review of the literature and recent advances. Indian J Urol 2007;23:452-7
   PubMedGoogle Scholar
• Langer R, Vacanti JP. Tissue engineering. Science 1993;260:920-6
   PubMed Web of Science ®Google Scholar
• Probst M, Dahiya R, Carrier S, Tanagho EA. Reproduction of functional smooth muscle tissue and partial bladder replacement. Br J Urol 1997;79:505-15
   PubMedGoogle Scholar
• Sutherland RS, Baskin LS, Hayward SW, Cunha GR. Regeneration of bladder urothelium, smooth muscle, blood vessels, and nerves into an acellular tissue matrix. J Urol 1996;156:571-7
   PubMed Web of Science ®Google Scholar
• Piechota HJ, Dahms SE, Nunes LS, et al. In vitro functional properties of the rat bladder regenerated by the bladder acellular matrix graft. J Urol 1998;159:1717-24
   PubMed Web of Science ®Google Scholar
• Oberpenning FO, Meng J, Yoo J, Atala A. De novo reconstitution of a functional urinary bladder by tissue engineering. Nat Biotechnol 1999;17:149-55
   PubMed Web of Science ®Google Scholar
• Imamura T, Yamamoto T, Ishizuka O, et al. The microenvironment of freeze-injured mouse urinary bladders enables successful tissue engineering. Tissue Eng Part A 2009;15:3367-75
   PubMed Web of Science ®Google Scholar
• Atala A, Bauer SB, Soker S, et al. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 2006;367:1241-6
   PubMed Web of Science ®Google Scholar
• Fraser M, Thomas DF, Pitt E, et al. A surgical model of composite cystoplasty with cultured urothelial cells: a controlled study of gross outcome and urothelial phenotype. BJU Int 2004;93:609-16
   PubMed Web of Science ®Google Scholar
• Turner A, Subramanian R, Thomas DF, et al. Transplantation of autologous differentiated urothelium in an experimental model of composite cystoplasty. Eur Urol 2011;59:447-54
   PubMed Web of Science ®Google Scholar
• Rodriguez LV, Alfonso Z, Zhang R, et al. Clonogenic multipotent stem cells in human adipose tissue differentiate into functional smooth muscle cells. Proc Natl Acad Sci USA 2006;103:12167-72
   PubMed Web of Science ®Google Scholar
• Tian H, Bharadwaj S, Liu Y, et al. Myogenic differentiation of human bone marrow mesenchymal stem cells on a 3D nano fibrous scaffold for bladder tissue engineering. Biomaterials 2010;31:870-7
   PubMed Web of Science ®Google Scholar
• Kinebuchi Y, Johkura K, Sasaki K, et al. Direct induction of layered tissues from mouse embryonic stem cells: potential for differentiation into urinary tract tissue. Cell Tissue Res 2008;331:605-15
   PubMed Web of Science ®Google Scholar
• Chung SY, Krivorov NP, Rausei V, et al. Bladder reconstitution with bone marrow derived stem cells seeded on small intestinal submucosa improves morphological and molecular composition. J Urol 2005;174:353-9
   PubMed Web of Science ®Google Scholar
• Ringdén O, Uzunel M, Sundberg B, et al. Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon. Leukemia 2007;21:2271-6
   PubMed Web of Science ®Google Scholar
• Shaikh R, Raj Singh TR, Garland MJ, et al. Mucoadhesive drug delivery systems. J Pharm Bioallied Sci 2011;3:89-100
   PubMed Web of Science ®Google Scholar